Medical Consulting for Ancillary Supplies in Clinical Trials

Guidance That Connects Protocol to Product

Ancillary supplies may not be investigational, but they are essential. Ancillare’s medical consulting services ensure every supply choice — from syringes to storage devices — is clinically appropriate, globally sourced, and aligned with your trial’s protocol.

Our in-house medical supply experts provides early input during planning and protocol review, working alongside supply chain and regulatory teams to identify the right products and mitigate risk before issues arise.

Built Into the Supply Chain, Not Bolted On

Unlike traditional sourcing vendors, Ancillare integrates medical consulting directly into our Clinical Trial Ancillary Supply Chain (CTASC) model. That means Sponsors and CROs benefit from:

Therapeutic-area-informed supply recommendations
Global product availability analysis
Clinical justification for substitutions or equivalents
Input on usability, compatibility, and safety at the site level
Proactive risk identification (e.g., cold chain sensitivities, storage challenges)

Why It Matters for Your Trial and Your Patient

A mismatched supply does not just delay a study — it can put patients at risk. Ancillare’s consultative approach helps ensure every supply and equipment delivered is appropriate for use, reducing variability and protecting both the trial and the individuals who rely on it.

Whether you are managing a rare disease study or scaling across regions, our medical supply consulting supports:

Safer drug administration
Fewer site-level issues
Regulatory confidence
On-time trial execution

Let’s Get It Right — From the Start

Ancillare helps Sponsors and CROs avoid costly mistakes and safeguard trial quality by bringing clinical insight to every supply decision.

With our patient-centric focus, we own supply chain success, ensuring trials launch on time with no regulatory delays related to ancillary supplies, so sites are supported, Sponsors’ objectives are fully met, and up to 30% cost savings can be realized.

Our portfolio is therapeutically diverse with extensive experience in the following areas: